Therapeutic Asset Ratings

7,021 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
VINCRISTINE SULFATE B-Cell Acute Lymphoblastic Leukemia	City of Hope Medical Center	P3	BB (71)
VINCRISTINE SULFATE Leukemia	Inhye Ahn	P3	BB (71)
VINCRISTINE SULFATE Lymphoma	Inhye Ahn	P3	BB (71)
Zofran Non-Hodgkin's Lymphoma	MEI Pharma, Inc.	P3	BB (71)
1-(18F)Fluoranyl-3-[[2-[(E)-4-[6-(methylamino)pyridin-3-yl]but-1-en-3-ynyl]-1,3-benzothiazol-6-yl]oxy]propan-2-ol Alzheimer Disease	JYAMS PET Research & Development Limited	P3	BB (70)
((3AR,6AS)-5-(4,6-DIMETHYLPYRIMIDIN- 2-YL)HEXAHYDROPYRROLO(3,4-C)PYRROL-2(1H)-YL)(2-FLUORO- 6-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE OREXIN RECEPTOR ANTAGONIST Major Depressive Disorder	Janssen Research & Development, LLC	P3	BB (70)
Abemaciclib Estrogen-Receptor Positive Breast Cancer	Jonsson Comprehensive Cancer Center	P3	BB (70)
Adebrelimab Metastatic Colon Cancer	Sapience Therapeutics	P3	BB (70)
Anti-Thymoglobulin, Rabbit Disease Related To Hematopoietic Stem Cell Transplant	The First Affiliated Hospital of Soochow University	P3	BB (70)
Aoc 1044 Duchenne Muscular Dystrophy	Avidity Biosciences, Inc.	P3	BB (70)
ask120067 Non-Small Cell Lung Carcinoma	Jiangsu Aosaikang Pharmaceutical Co., Ltd.	P3	BB (70)
ASPARAGINASE Recurrent Childhood Acute Lymphoblastic Leukemia	Therapeutic Advances in Childhood Leukemia Consortium	P3	BB (70)
Atumelnant Classic Congenital Adrenal Hyperplasia	Crinetics Pharmaceuticals Inc.	P3	BB (70)
Atumelnant Congenital Adrenal Hyperplasia	Crinetics Pharmaceuticals Inc.	P3	BB (70)
Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA) introduced transiently as ribonucleoprotein (RNP) complex, targeting the erythroid lineage-specific enhancer region of BCL11A (B-cell lymphoma/leukemia 11A). The site-specific cleavage by Cas9 forms a double strand break (DSB), which is subsequently repaired by nonhomologous end-joining (NHEJ), leading to the transcriptional repression of BCL11A, a repressor of ?-globin gene transcription Hematologic Disorder	Vertex Pharmaceuticals Incorporated	P3	BB (70)
Axs-05 Alzheimer Disease	Axsome Therapeutics, Inc.	P3	BB (70)
Bendamustine B-Cell Chronic Lymphocytic Leukemia	Mayo Clinic	P3	BB (70)
Bendamustine Non-Hodgkin Lymphoma	MEI Pharma, Inc.	P3	BB (70)
Bexicaserin Developmental And Epileptic Encephalopathy	Longboard Pharmaceuticals	P3	BB (70)
Blinatumomab Precursor B-Cell Acute Lymphoblastic Leukemia	Amgen	P3	BB (70)
Bms-907351 Castration-Resistant Prostate Carcinoma	Rana McKay, MD	P3	BB (70)
Brentuximab Vedotin Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	Assistance Publique - Hôpitaux de Paris	P3	BB (70)
Brivaracetam Epilepsy	Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.	P3	BB (70)
Busulphan Acute Myeloid Leukemia With 11q23 Abnormalities	M.D. Anderson Cancer Center	P3	BB (70)
Busulphan Childhood Acute Erythroleukemia (M6)	Fred Hutchinson Cancer Center	P3	BB (70)

Showing 351 to 375 of 7,021 assets

PreviousPage 15 of 281Next